Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convalescent CoVID-19 Plasma in the Treatment of High Risk CoVID-19 Disease

NCT04355897 is registered in ClinicalTrials.gov with The Christ Hospital as lead sponsor.

NCT NCT04355897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04355897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convalescent CoVID-19 Plasma in the Treatment of High Risk CoVID-19 Disease
Lead sponsor
The Christ Hospital
Phase
Phase 1
Overall status
Completed
Start date
April 28, 2020
Completion date
August 12, 2020
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19